Searched over 200M research papers for "isc stroke"
10 papers analyzed
These studies suggest that ischemic stroke care involves consistent quality regardless of admission timing, various rehabilitative techniques like CIMT and acupuncture, interdisciplinary clinics for post-acute care, distinct mechanisms in cancer patients, significant lifetime costs, low IVT treatment rates, peer-to-peer audits for care improvement, and new findings on head position and medication efficacy.
20 papers analyzed
A study investigated whether the quality of care for acute ischemic stroke (AIS) patients admitted during the International Stroke Conference (ISC) differed from other times. The research found no significant differences in the quality of care or clinical outcomes between patients admitted during ISC weeks and those admitted during non-ISC weeks. This suggests that the presence of stroke clinicians at the conference does not negatively impact patient care.
Constraint-Induced Movement Therapy (CIMT) has shown promise in rehabilitating upper extremity functions post-ischemic stroke. Research using a rat model demonstrated that CIMT could restore skilled movements and improve fine motor skills. The therapy was found to enhance neural plasticity, as evidenced by increased dendritic arborization and re-establishment of axonal connections between hemispheres.
Interdisciplinary stroke clinics (ISCs) have been effective in identifying post-stroke patients who could benefit from additional rehabilitation. A study highlighted that a significant number of patients assessed in such clinics were recommended for further physical or occupational therapy. Key assessment tools like the Ten-Meter Walk Test (10MWT) and the Short Form-Stroke Impact Scale (SF-SIS) were instrumental in these evaluations.
Ischemic strokes in cancer patients (ISC) exhibit unique characteristics compared to non-cancer patients. Patients with active cancer showed higher levels of C-reactive protein (CRP) and D-dimer, more frequent cryptogenic strokes, and distinct diffusion-weighted imaging (DWI) lesion patterns. These differences were not observed in patients with inactive cancer, indicating that active cancer status significantly influences stroke mechanisms and risk factors.
The economic burden of ischemic stroke (ISC) is substantial. A study estimated the lifetime cost per person for ischemic stroke at approximately $90,981, with indirect costs accounting for 58% of the total. The aggregate lifetime cost for all first strokes in 1990 was estimated at $40.6 billion, with ischemic strokes contributing $29.0 billion to this total. These costs highlight the long-term financial impact of stroke on individuals and society.
A study on inpatient stroke codes (ISC) revealed a significant treatment gap in the administration of intravenous thrombolytic (IVT) therapy. Despite a considerable number of patients being eligible for IVT, only a small fraction received the treatment. The most common reason for not administering IVT was a low National Institutes of Health Stroke Scale (NIHSS) score, indicating a need for better identification and treatment protocols.
The presentation of endovascular stroke treatment trials at the ISC in 2015 marked a significant advancement in stroke care. These trials have positively influenced the time to presentation for acute ischemic strokes, emphasizing the importance of timely treatment in improving outcomes.
Recent research underscores the importance of consistent care quality, effective rehabilitation strategies, and addressing treatment gaps in ischemic stroke management. The distinct characteristics of ischemic strokes in cancer patients and the substantial economic burden further highlight the need for tailored approaches and efficient resource allocation. Continuous advancements in stroke care, driven by clinical trials and interdisciplinary efforts, are crucial for improving patient outcomes.
Most relevant research papers on this topic